Pharmacokinetics, Safety and Antiviral Activity of Fosamprenavir/Ritonavir-containing Regimens in HIV-infected Children Aged 4 Weeks to 2 Years—48-week Study Data

BACKGROUND: Pharmacokinetics, safety and antiviral activity of fosamprenavir (FPV) with ritonavir (RTV) twice daily were evaluated in HIV-1–infected infants and children 4 weeks to <2 years over 48 weeks. METHODS: Results from intensive pharmacokinetic sampling of subjects enrolled in single dose...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cotton, Mark, Cassim, Haseena, Pavía-Ruz, Noris, Garges, Harmony P., Perger, Teodora, Ford, Susan L., Wire, Mary Beth, Givens, Naomi, Ross, Lisa L., Lou, Yu, Sievers, Jörg, Cheng, Katharine
Formato: Artigo
Idioma:Inglês
Publicado em: Williams & Wilkins 2014
Assuntos:
HIV Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3882303/
https://ncbi.nlm.nih.gov/pubmed/23811743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e3182a1123a
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados